Of note, we identified the potential inhibition effects of LSM12, LSM14A, and LSM14B on tumor immunity, which laid a novel foundation to further explore the role of LSM family members as novel potential therapeutic targets in HCC. The gene discussed is LSM14B; the disease is neoplasm.